ημχ δφξη | ΰιλειεϊ | ψλιαιν τςιμιν | δϊεειεϊ | ξιπεπιν | ψβιωεϊ | ϊετςεϊ μεεΰι |
ξιπεο ιϊψ | ΰζδψεϊ | δϊεειεϊ πβγ | ψςιμεϊ | ΰιπθψΰχφιεϊ | δψιεο | δπχδ
ξεφΰε ωμ δφξη αγψεν εξζψη ΰτψιχδ.
αιωψΰμ, ξωψγ δαψιΰεϊ ξβαιμ ΰϊ δωιξεω δτπιξι αχμιτϊ ςμδ δΰμεεψδ, εξϊιψ ΰεϊδ μωιεεχ ααϊι ξψχηϊ αμαγ. δβ'μ ξεϊψ μωιεεχ.
ημχι δφξη αωιξεω
ηεξψ ψιψι (β'μ) δξφει αϊεκ δςμδ
χμιτϊ δςμδ
ΰιλειεϊ
θξτψθεψδ: χψ
μηεϊ: μη
θςν: ξψ (χμιτϊ δςμδ)
ψλιαιν τςιμιν ςιχψιιν
β'μ – τεμιρλψιγιν, ηεξψιν ψιψιιν (ξεφιμΰβιν).
χμιτϊ δςμδ – ΰπθψΰχιπεπιν (aloin, aloeemodin, barbaloin).
δϊεειεϊ
β'μ ΰμεεψδ:
ωιξεω τπιξι – ξημεϊ γμχϊιεϊ ελιαιεϊ ωμ δξςιιν, λια ττθι (ΰεμχερ), τφςιν αγψλι δςιλεμ.
ωιξεω ηιφεπι – λεειεϊ, τιρεψδ ΰπΰμιϊ, τρεψιΰζιρ (ρτηϊ), τψιηεϊ ετφςιν, ηϊλιν, ωψιθεϊ.
χμιτϊ δςμδ:
ωιξεω τπιξι – ςφιψεϊ.
ξιπεπιν
β'μ ΰμεεψδ:
αωιξεω τπιξι: ξωχδ δξετχ ξδβ'μ – 15-30 ξ"μ αιεν.
αωιξεω ηιφεπι: λ-5% ϊξφιϊ αψιλεζ 200:1 (A. barbadensis) αϊεκ β'μ ΰε χψν αριρ.
χμιτϊ δςμδ:
ϊξφιϊ πεζμιϊ αψιλεζ 1:10, 25% ΰμλεδεμ + 25% βμιφψιο – 1.5-4 ξ"μ αιεν (μτι δφεψκ).
ϊξφιϊ ιαωδ ϊχπιϊ αψιλεζ 5:1 – 50-200 ξ"β αιεν, μτι δφεψκ (αγ"λ μτπι δωιπδ).
ψβιωεϊ
χιιξιν γιεεηιν ςμ μξιγς δωμν μξπειιν
ϊετςεϊ μεεΰι εξιπεο ιϊψ
β'μ ΰμεεψδ: αμχιηδ τπιξιϊ ΰιο γιεεηιν ξωξςεϊιιν ςμ ϊετςεϊ μεεΰι; πηωα αθιηεϊι μωιξεω.
χμιτϊ δςμδ: ϊετςεϊ μεεΰι ςωειεϊ μλμεμ μξιγς δωμν μξπειιν
ΰζδψεϊ εφςγι ξπς
β'μ ΰμεεψδ: ωιξεω αβ'μ ςωει μδτηιϊ ΰϊ μξιγς δωμν μξπειιν
χμιτϊ δςμδ: ξωμωμιν ξξψιφιν ςωειιν μδτηιϊ ΰϊ μξιγς δωμν μξπειιν
δϊεειεϊ πβγ
β'μ ΰμεεψδ: μΰ ιγες ςμ δϊεειεϊ πβγ.
χμιτϊ δςμδ: ΰμεεψδ ξΰεγ ξβψδ ΰϊ δξςιιν εμλο ΰρεψδ μωιξεω μξιγς δωμν μξπειιν
ψςιμεϊ
μΰ πφτϊδ ψςιμεϊ λμωδι αωιξεω αΰμεεψδ αξιπεπιν δψτεΰιιν δξχεαμιν(1).
ξγγ ψςιμεϊLD50: μξιγς δωμν μξπειιν
ϊβεαεϊ δγγιεϊ ςν ϊψετεϊ / φξηι ξψτΰ / ϊερτι ϊζεπδ
β'μ ΰμεεψδ | χμιτϊ δςμδ | δφξη δωμν
β'μ ΰμεεψδ:
ηιμεσ ηεξψιν ϊψετϊι | δψγξδ | δεψγϊ ρελψ | πεβγι HIV | πεβγεϊ γμχϊ ρθψεΰιγιμιεϊ | NSAIDs | ρεϊψι ηεξφδ ξςλαι διρθξιο (cimetidine) | ηερξι αθΰ | εΔιθξιο BΔ12 | εΔιθξιο E | εΔιθξιο C | τψετεμιρ | λιξεϊψτιδ ξρεβ φιρτμθιο | ψγιεϊψτιδ
ηιμεσ ηεξψιν ϊψετϊι - μξιγς δωμν μξπειιν
ϊψετεϊ δψγξδ -μξιγς δωμν μξπειιν
ϊψετεϊ μδεψγϊ ρελψ - μξιγς δωμν μξπειιν
πεβγι HIV - μξιγς δωμν μξπειιν
πεβγεϊ γμχϊ ρθψεΰιγιμιεϊ - μξιγς δωμν μξπειιν
NSAID's - μξιγς δωμν μξπειιν
ρεϊψι ηεξφδ ξςλαι διρθξιο- μξιγς δωμν μξπειιν
ηερξι αθΰ- μξιγς δωμν μξπειιν
εΔιθξιο B1Δ2- μξιγς δωμν μξπειιν
εΔιθξιο E- μξιγς δωμν μξπειιν
εΔιθξιο C- μξιγς δωμν μξπειιν
τψετεμιρ- μξιγς δωμν μξπειιν
λιξεϊψτιδ (Cisplatin) – μξιγς δωμν μξπειιν
ψγιεϊψτιδ- μξιγς δωμν μξπειιν
χμιτϊ δςμδ:
ηιμεσ ηεξψιν ϊψετϊι | δργψϊ χφα μα | ξωϊπεϊ ωΰιπο ΰεφψεϊ ΰωΐμβο (ϊιΰζιγιν εξωϊπι μεμΰδ) | ξωμωμεϊ | χεψθιχερθψεΰιγιν | δψγξδ
ηιμεσ ηεξψιν ϊψετϊι μξιγς δωμν μξπειιν
ϊψετεϊ μδργψϊ χφα μα μξιγς δωμν μξπειιν
ϊψετεϊ ξωϊπεϊ ωΰιπο ΰεφψεϊ ΰωΐμβο (ϊιΰζιγιν εξωϊπι μεμΰδ) μξιγς δωμν μξπειιν
ϊψετεϊ ξωμωμεϊ μξιγς δωμν μξπειιν
ϊψετεϊ χεψθιχερθψεΰιγιν μξιγς δωμν μξπειιν
ϊψετεϊ δψγξδ μξιγς δωμν μξπειιν
δφξη δωμν:
ηιμεσ ηεξψιν ϊψετϊι | φιχμερτεψιο | δψγξδ | Gentamicin | ρεϊψι ηεξφδ ξςλαι διρθξιο (cimetidine) | ηερξι αθΰ | λιξεϊψτιδ ξρεβ Cisplatin, Etoposide, Vinorelbine, Oxaliplatin, Gemcitabine | λιξεϊψτιδ Fluorouracil (5-FU) | λιξεϊψτιδ ξρεβ doxorubicin, iminatib, Tamoxifen | εΔιθξιο BΔ12 | εΔιθξιο E | εΔιθξιο C | ξμθεπιο
ηιμεσ ηεξψιν ϊψετϊι μξιγς δωμν μξπειιν
φιχμερτεψιο μξιγς δωμν μξπειιν
ϊψετεϊ δψγξδ μξιγς δωμν μξπειιν
ϊψετϊ Gentamicin μξιγς δωμν μξπειιν
ρεϊψι ηεξφδ ξςλαι διρθξιο- μξιγς δωμν μξπειιν
ηερξι αθΰ- μξιγς δωμν μξπειιν
λιξεϊψτιδ ξρεβ Cisplatin, Etoposide, Vinorelbine, Oxaliplatin, Gemcitabine μξιγς δωμν μξπειιν
λιξεϊψτιδ Fluorouracil (5-FU) μξιγς δωμν μξπειιν
λιξεϊψτιδ ξρεβ doxorubicin, iminatib Tamoxifen μξιγς δωμν μξπειιν
εΔιθξιο B1Δ2- μξιγς δωμν μξπειιν
εΔιθξιο E- μξιγς δωμν μξπειιν
εΔιθξιο C- μξιγς δωμν μξπειιν
ξμθεπιο μξιγς δωμν μξπειιν
δψιεο
β'μ ΰμεεψδ: ΰμεεψδ ΰτωψι μωιξεω τπιξι αϊχετϊ δδψιεο. ψφει μςωεϊ λο μξιγς δωμν μξπειιν
χμιτϊ δςμδ: δωιξεω αχμιτϊ ΰμεεψδ ΰιπε ξεξμυ μωιξεω τπιξι αδψιεο εαπωιν δψεφεϊ μδψεϊ(1,2).
δπχδ
β'μ ΰμεεψδ: ΰτωψι μωιξεω τπιξι αϊχετϊ δδπχδ. ψφει μςωεϊ λο μξιγς δωμν μξπειιν
χμιτϊ δςμδ: δωιξεω αχμιτϊ ΰμεεψδ αζξο δπχδ φψικ μδιεϊ ξμεεδ α μξιγς δωμν μξπειιν
ξχεψεϊ
- Stargrove M B, Treasure J,McKee D. L, Herb, Nutrient, and Drug Interactions, Elsevier, 2008. https://www.us.elsevierhealth.com/herb-nutrient-and-drug-interactions-9780323029643.html.
- Brinker F. Herb Contraindications and Drug Interactions, 4th ed. Sandy (OR): Eclectic Medical Publications; 2010. https://www.eclecticherb.com/herb-contraindications-drug-interactions
- Reynolds, T. and Dweck, A. C. Aloe vera leaf gel: a review update. J Ethnopharmacol. 12-15-1999;68(1-3):3-37. https://www.ncbi.nlm.nih.gov/pubmed/10624859.
- Wohlrab, J., Kreft, B., and Tamke, B. Skin tolerability of transdermal patches. Expert.Opin.DrugDeliv. 2011;8(7):939-948. https://www.ncbi.nlm.nih.gov/pubmed/21506903.
- Mills. S, Bone K, The Essential Guide to Herbal Safety. Churchill Livingstone, 2005. https://www.elsevier.com/books/the-essential-guide-to-herbal-safety/mills/978-0-443-07171-3.
- Yang HN, Kim DJ, Kim YM, et al. Aloe-induced toxic hepatitis. J Korean Med Sci. 2010 Mar;25(3):492-5. https://www.ncbi.nlm.nih.gov/pubmed/20191055.
- Siegers CP, von Hertzberg-Lottin E, Otte M, Schneider B. Anthranoid laxative abuse--a risk for colorectal cancer? Gut. 1993 Aug;34(8):1099-101. https://www.ncbi.nlm.nih.gov/pubmed/8174962.
- Pigatto, P.D.; Guzzi, G. Aloe linked to thyroid dysfunction. Arch. Med. Res 2005, 36(5), 608. http://zjrms.ir/files/site1/user_files_10e1c1/vahidasgary-A-10-1431-1-c525cc7.pdf.
- Yongchaiyudha S, Rungpitarangsi V, Bunyapraphatsara N, and et al. Antidiabetic activity of Aloe vera L. juice. I Clinical trial in new cases of diabetes mellitus. Phytomedicine 1996;3(3):241-243. https://www.ncbi.nlm.nih.gov/pubmed/23195077.
- Bunyapraphatsara N, Yongchaiyudha S, Rungpitarangsi V, and et al. Antidiabetic activity of Aloe vera L. juice. II. Clinical trial in diabetes mellitus patients in combination with glibenclamide. Phytomed 1996;3(3):245-248. https://www.ncbi.nlm.nih.gov/pubmed/23195078.
- Huseini, H. F., Kianbakht, S., Hajiaghaee, R., and Dabaghian, F. H. Anti-hyperglycemic and anti-hypercholesterolemic effects of Aloe vera leaf gel in hyperlipidemic type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Planta Med. 2012;78(4):311-316. https://www.ncbi.nlm.nih.gov/pubmed/22198821
- Vogler, B. K. and Ernst, E. Aloe vera: a systematic review of its clinical effectiveness. Br.JGen.Pract. 1999;49(447):823-828. https://www.ncbi.nlm.nih.gov/pubmed/10885091.
- Hamman, J., 2008. Composition and applications of aloe vera leaf gel. Molecules 13, 1599–1616. https://www.ncbi.nlm.nih.gov/pubmed/18794775
- Ezuruike UF, Prieto JM. The use of plants in the traditional management of diabetes in Nigeria: pharmacological and toxicological considerations. J Ethnopharmacol. 2014 Sep 11;155(2):857-924. https://www.ncbi.nlm.nih.gov/pubmed/24929108
- Choudhary, M., A. Kochhar, and J. Sangha. 2014. Hypoglycemic and hypolipidemic effect of Aloe vera L. in non-insulin dependent diabetics. Journal of Food Science and Technology 51: 90–96. https://www.ncbi.nlm.nih.gov/pubmed/24426052
- Choi, H.C., S.J. Kim, K.Y. Son, B.J. Oh, and B.L. Cho. 2013. Metabolic effects of aloe vera gel complex in obese prediabetes and early non-treated diabetic patients: Randomized controlled trial. Nutrition 29: 1110–1114. https://www.ncbi.nlm.nih.gov/pubmed/23735317
- Yagi, A. 2014. Possible efficacy of aloe vera gel metabolites in longterm ingestion to insulin sensitivity. Journal of Gastroenterology and Hepatology Research 3: 996-1005. http://www.ghrnet.org/index.php/joghr/article/view/623
- Rehman SU, Choi MS, Choe K, Yoo HH. Interactions between herbs and antidiabetics: an overview of the mechanisms, evidence, importance, and management. Arch Pharm Res. 2015 Jul;38(7):1281-98. https://www.ncbi.nlm.nih.gov/pubmed/25475096
- Yun, J. M., Singh, S., Jialal, R., Rockwood, J., Jialal, I., and Devaraj, S. A randomized placebo-controlled crossover trial of Aloe vera on bioavailability of vitamins C and B(12), blood glucose, and lipid profile in healthy human subjects. J.Diet.Suppl 2010;7(2):145-153. https://www.ncbi.nlm.nih.gov/pubmed/22435613.
- Vinson, J. A., Al Kharrat, H., and Andreoli, L. Effect of Aloe vera preparations on the human bioavailability of vitamins C and E. Phytomedicine 2005;12(10):760-765. https://www.ncbi.nlm.nih.gov/pubmed/16323295.
- Hussain A, Sharma C, Khan S, Shah K, Haque S. Aloe vera inhibits proliferation of human breast and cervical cancer cells and acts synergistically with cisplatin. Asian Pac J Cancer Prev. 2015;16(7):2939-46. https://www.ncbi.nlm.nih.gov/pubmed/25854386.
- Hoopfer D, et al. Three-Arm Randomized Phase III Trial: Quality Aloe and Placebo Cream Versus Powder as Skin Treatment During Breast Cancer Radiation Therapy. Clin Breast Cancer. 2015 Jun;15(3):181-90.e1-4. Epub 2014 Dec 24. https://www.ncbi.nlm.nih.gov/pubmed/25619686.
- McDaniel, H., C.H.R.M. COmbs, Carpenter R, M. Kemp, B. McAnalley, 1990. An increase in circulating monocyte/macrophages (M/M) is induced by oral acemannan in HIV-1 patients. Am J Clin Pathol, 94: 516-7. https://pdfs.semanticscholar.org/B2ce/ee50bf076a9063da99577B6f15f82f904348.pdf.
- McDaniel, H., R. Carpenter, M. Kemp, J. Kahlon, B. McAnalley, 1990. Extended survival and prognostic criteria for Acemannan (ACE-M) treated HIV Patients. Antiviral Res Suppl, 1: 117. https://pdfs.semanticscholar.org/B2ce/ee50bf076a9063da99577B6f15f82f904348.pdf.
- M. C. Kemp, J. B. Kahlon, A. D. Chinnah, R. H. Carpenter, B. H. McAnalley, H. R. McDaniel and W. M. Shannon, “In Vitro Evaluation of the Antiviral Effects of Acemannan on the Replication and Pathogenesis of HIV-1 and Other Enveloped Viruses: Modification of the Processing of Glycoprotein Glycoprotein Precursors,” Antiviral Res, Vol. 13, Suppl. 1, 1990, p. 83. https://www.sciencedirect.com/science/article/pii/0166354290901562?via%3Dihub.
- Kahlon, J.B., M.C. Kemp, N. Yawei, R.H. Carpenter, W.M. Shannon, B.H. McAnalley, 1991. In vitro evaluation of the synergistic antiviral effects of acemannan in combination with azidothymidine and acyclovir. Mol Biother, 3: 214-23. https://www.ncbi.nlm.nih.gov/pubmed/1662957.
- Montaner JS, Gill J, Singer J, Raboud J, Arseneau R, McLean BD, Schechter MT, Ruedy J. Double-blind placebo-controlled pilot trial of acemannan in advanced human immunodeficiency virus disease. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jun 1;12(2):153-7. https://www.ncbi.nlm.nih.gov/pubmed/8680886.
- Djuv A, Nilsen OG. Aloe Vera Juice: IC(50) and Dual Mechanistic Inhibition of CYP3A4 and CYP2D6. Phytother Res. 2011 Aug 15. doi: 10.1002/ptr.3564. https://www.ncbi.nlm.nih.gov/pubmed/21842479.
- Westendorf J. Anthranoid derivatives-general discussion. In: De Smet P, Keller K, Hansel R, et al, eds. Adverse Effects of Herbal Drugs. Vol 2. Berlin, Germany: Springer; 1993:105–118.
- Surjushe A, Vasani R, Saple D. Aloe vera: a short review. Indian J Dermatol. 2008;53:163–166. https://www.ncbi.nlm.nih.gov/pubmed/19882025
- Alissa EM. Medicinal herbs and therapeutic drugs interactions. Ther Drug Monit. 2014 Aug;36(4):413-22. https://www.ncbi.nlm.nih.gov/pubmed/24452064
- Blumenthal M (ed.). The Complete German Commission E Monographs. Integrative Medicine Communications, Boston, Mass., 1998. https://www.elsevier.com/books/the-complete-german-commission-e-monographs/unknown/978-0-9655555-0-0
- Gruenwald J, Brendler T, Jaenicke C (eds.). PDR for Herbal Medicines. Medical Economics Co., Inc., Montvale, NJ, 1998. https://www.travolekar.ru/arch/Pdr_for_Herbal_Medicines.pdf
- De Smet PAGM et al. (eds.). Adverse Effects of Herb Drugs 2. Springer-Verlag, Berlin, 1993.
- Lee A, Chui PT, Aun CST, et al. Possible interaction between sevoflurane and Aloe vera. Ann. Pharmacother., 38:1651-1654, 2004. https://www.ncbi.nlm.nih.gov/pubmed/15292490.
- Vazquez B, Avila G, Segura D, et al. Antiinflammatory activity of extracts from Aloe vera gel. J. Ethnopharm., 55:69-75, 1996. https://www.ncbi.nlm.nih.gov/pubmed/9121170.
- Lissoni, P., Rovelli, F., Brivio, F., Zago, R., Colciago, M., Messina, G., Mora, A., and Porro, G. A randomized study of chemotherapy versus biochemotherapy with chemotherapy plus Aloe arborescens in patients with metastatic cancer. In Vivo 2009;23(1):171-175. https://www.ncbi.nlm.nih.gov/pubmed/19368145
γεβξΰ μξεπεβψσ ξμΰ
μψλιωϊ ξπει |
λπιρϊ ξπειιν